United Therapeutics Corp
UTHR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001082554
In the last 90 days, United Therapeutics Corp insiders filed 0 open-market purchases and 69 sales; 886 institutions reported holding it in 13F filings for Q2 2026, worth $22.6B in total; no superinvestor holds it.
Superinvestors holding UTHR, Q2 2026
No superinvestor reported holding UTHR in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of UTHR each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q1 2024
1 superinvestor holding at quarter end
Q4 2021
0 superinvestors holding at quarter end
- Sold out
- Maverick Capital
Q3 2021
1 superinvestor holding at quarter end
- Reduced
- Maverick Capital (−47.8%)
Q2 2021
1 superinvestor holding at quarter end
- Added
- Maverick Capital (+11.2%)